Product Information
BROMPHEN-PSE-DM 2-30-10 MG/5 ML is a generic product labeled by Eywa Pharma Inc, priced at $0.0682 per ML under NDC 71930002643. Its NADAC has been published 302 times since Dec 23, 2020.
FDA first approved this application on Jun 16, 2020. Its Orange Book therapeutic-equivalence code is AA.
Strength
2; 10; 30 mg/5mL; mg/5mL; mg/5mL
Manufacturer
Eywa Pharma IncNDC
71930002643
Classification
Generic
Dosage Form
SYRUP
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211170FDA Approved
6/16/2020
TE Code
AA
On Market Since
6/26/2020
Pharmacological Classes
Price Statistics
The NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has been published 302 times since Dec 23, 2020, and over the history we have for it it has risen 12.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0682 per ML |
|---|---|
| All-time high | $0.1053 (Dec 11, 2024) |
| All-time low | $0.0503 (Aug 17, 2022) |
| 52-week high | $0.0862 |
| 52-week low | $0.0682 |
| Median price | $0.0728 |
| Average price | $0.0743 |
| Largest weekly change | +26.0% (Mar 23, 2022) |
| Weeks tracked | 302 |
| Tracking since | Dec 23, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Brompheniramine maleate, pseudoephedrine hydrochloride, market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eywa Pharma Inc manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Brompheniramine maleate, pseudoephedrine hydrochloride, market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sigma-1 Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BROMPHEN-PSE-DM 2-30-10 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for BROMPHEN-PSE-DM 2-30-10 MG/5 ML, manufactured by Eywa Pharma Inc, is $0.0682 per ML (NDC 71930002643), effective Sep 30, 2026.
How has the price of BROMPHEN-PSE-DM 2-30-10 MG/5 ML changed over time?
Over the history we have for it, the NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has risen 12.3%. It has been tracked across 302 weekly CMS publications since Dec 23, 2020.
What are the highest and lowest recorded NADAC prices for BROMPHEN-PSE-DM 2-30-10 MG/5 ML?
Since Dec 23, 2020, the NADAC for BROMPHEN-PSE-DM 2-30-10 MG/5 ML has ranged from a low of $0.0503 (Aug 17, 2022) to a high of $0.1053 (Dec 11, 2024), with a median of $0.0728 per ML.
Are there cheaper alternatives to BROMPHEN-PSE-DM 2-30-10 MG/5 ML?
No other NADAC-published product currently shares the active ingredient and strength of BROMPHEN-PSE-DM 2-30-10 MG/5 ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BROMPHEN-PSE-DM 2-30-10 MG/5 ML?
BROMPHEN-PSE-DM 2-30-10 MG/5 ML (NDC 71930002643) is labeled by Eywa Pharma Inc, and CMS classifies it as a generic product.